Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 215-242-4 | CAS number: 1314-80-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Non-GLP, guideline-comparable proprietary study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 974
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- other: Code of Federal Regulations (Part 191.1)
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Principles of method if other than guideline:
- No further information
- GLP compliance:
- no
- Remarks:
- : study pre-dates GLP
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Diphosphorus pentasulphide
- EC Number:
- 215-242-4
- EC Name:
- Diphosphorus pentasulphide
- Cas Number:
- 1314-80-3
- Molecular formula:
- P2S5
- IUPAC Name:
- [(disulfanylidene-λ⁵-phosphanyl)sulfanyl]-λ⁵-phosphanedithione
- Details on test material:
- The test material is described as a light yellow powder
Constituent 1
Test animals
- Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- New Zealand white albino rabbits in the 1.8-2.3 weight range were used in this study. Two male and two female rabbits were selected.
Administration / exposure
- Type of coverage:
- occlusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- Two male and two female rabbits had the test substance applied tot he closely clipped, intact abdominal skin beneath a protective binder. After 24 hours, the test material was removed and the abdominal skin inspected for irritation. The test site was washed with water and rewrapped in a gauze binder. The rabbits were monitored for a further 14-day period.
- Duration of exposure:
- The test substance was applied for 24 hours to intact, clipped skin. The skin was then washed and rewrapped in a gauze binder. The rabbits were then monitored for a further 14 days.
- Doses:
- The four dose levels used were 1000, 2150, 4540 and 10000 mg/kg bw.
- No. of animals per sex per dose:
- Two
- Control animals:
- no
- Details on study design:
- Four New Zealand white albino rabbits in the 1.8-2.3 weight range were used in this study. Two male and two female rabbits had the test material applied to the abdominal skim beneath a protective binder. After 24 hours, the binder was removed and the abdominal skin inspected for irritation. The test site was then washed with soap and water and rewrapped in a gauze binder. The test animals were observed for a 14 day period following the initial treatment.
- Statistics:
- None
Results and discussion
- Preliminary study:
- No preliminary study
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 3 160 mg/kg bw
- 95% CL:
- 2 151 - 4 639
- Mortality:
- At a dose level of 1000 mg/kg and 2150 mg/kg there was no mortalities. At a dose level of 4640 and 10,000 mg/kg there was 100% mortality.
- Clinical signs:
- other: At the 4640 mg/kg dose level the rabbits were observed to be moderately depressed after exposure to the test substance. At the 1000 and 2150 mg/kg dose levels rabbits had mild to moderate necrosis except one rabbit at the 1000 level who was free from irr
- Gross pathology:
- No autopsies were performed on the animals.
- Other findings:
- No further findings.
Any other information on results incl. tables
At the 4640 mg/kg bw dose level the rabbits were observed to be moderately depressed after exposure to the test substance. At the 1000 and 2150 mg/kg bw dose levels, rabbits had mild to moderate necrosis except one rabbit at the 1000 mg/kg bw dose level, which was free from irritation. At the 4540 mg/kg bw dose level, one rabbit had slight oedema and the remaining three had oedema, necrosis and severe erythema.
At dose level of 1000 mg/kg and 2150 mg/kg there were no mortalities. At dose levels of 4640 and 10000 mg/kg bw, there was 100% mortality.
Mortality in the rabbit
Dose level (mg/kg bw) |
|||
1000 |
2150 |
4640 |
10000 |
0/4 |
0/4 |
4/4 |
4/4 |
Applicant's summary and conclusion
- Interpretation of results:
- relatively harmless
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The LD50 was determined to be 3160 mg/kg bw under the condiitons of this study. Classification for acute dermal toxicity is not required.
- Executive summary:
The acute dermal toxicity of phosphorus pentasulphide was investigated in rabbits. The test substance was applied for 24 hours under occlusive conditions at dose levels of 1000, 2150, 4540 and 10000 mg/kg bw. Animals were observed for 14 days.
At the 4640 mg/kg bw dose level the rabbits were observed to be moderately depressed after exposure to the test substance. At the 1000 and 2150 mg/kg bw dose levels, rabbits had mild to moderate necrosis except one rabbit at the 1000 mg/kg bw dose level, which was free from irritation. At the 454 mg/kg bw dose level, one rabbit had slight oedema and the remaining three had oedema, necrosis and severe erythema.
At a dose level of 1000 mg/kg and 2150 mg/kg there were no mortalities. At dose levels of 4640 and 10000 mg/kg bw, there was 100% mortality. The dermal LD50 was calculated to be 3160 mg/kg bw.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.